Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A WhatsApp chatbot is nudging more people to get screened for colorectal cancer. A randomized trial in Hong Kong found that a theory-based chatbot intervention boosted colorectal cancer (CRC) screening uptake by ~30% compared to standard text reminders. The chatbot tailored messages to each user's readiness to screen and provided personalized risk assessments — and the gains held up at six months.
A randomized controlled trial out of Hong Kong found that a theory-based WhatsApp chatbot outreach (WCO) intervention significantly increased colorectal cancer (CRC) screening uptake compared to a standard text reminder (STR). The chatbot assessed each participant's readiness to screen using the Transtheoretical Model, then delivered personalized health education and risk assessments — or directed ready participants to nearby primary care doctors. The trial enrolled 500 asymptomatic adults aged 50–75 who were eligible for government-subsidized fecal immunochemical test (FIT) screening.
The results were clear: the chatbot group outperformed the text-reminder group at both 3 and 6 months, with no meaningful difference in how quickly participants completed screening once they decided to act.
By the Numbers
Why it matters: With CRC being one of the most preventable cancers through early detection, scalable digital tools like this chatbot could be a meaningful asset — especially in settings where healthcare manpower is limited. The low-cost, mobile-first approach integrates seamlessly into existing screening programs, making it a practical model for broader adoption.
